• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ALCAM/CD166:一种多功能细胞黏附、干细胞特性和癌症进展的介导体。

ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression.

机构信息

Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Química Biológica, Buenos Aires, Argentina; CONICET-Universidad de Buenos Aires, Instituto de Química y Fisicoquímica Biológicas (IQUIFIB) Prof. Alejandro C. Paladini, Buenos Aires, Argentina.

Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Buenos Aires, Argentina; Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina.

出版信息

Cytokine Growth Factor Rev. 2021 Oct;61:27-37. doi: 10.1016/j.cytogfr.2021.07.001. Epub 2021 Jul 9.

DOI:10.1016/j.cytogfr.2021.07.001
PMID:34272152
Abstract

Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) is a glycoprotein involved in homotypic and heterotypic cell adhesion. ALCAM can be proteolytically cleaved at the cell surface by metalloproteases, which generate shedding of its ectodomain. In various tumors, ALCAM is overexpressed and serves as a valuable prognostic marker of disease progression. Moreover, CD166 has been identified as a putative cancer stem cell marker in particular cancers. Herein, we summarize biochemical aspects of ALCAM, including structure, proteolytic shedding, alternative splicing, and specific ligands, and integrate this information with biological functions of this glycoprotein including cell adhesion, migration and invasion. In addition, we discuss different patterns of ALCAM expression in distinct tumor types and its contribution to tumor progression. Finally, we highlight the role of ALCAM as a cancer stem cell marker and introduce current clinical trials associated with this molecule. Future studies are needed to define the value of shed ALCAM in biofluids or ALCAM isoform expression as prognostic biomarkers in tumor progression.

摘要

激活白细胞细胞黏附分子(ALCAM/CD166)是一种参与同质和异质细胞黏附的糖蛋白。ALCAM 可以在细胞表面被金属蛋白酶进行蛋白水解切割,从而产生其细胞外结构域的脱落。在各种肿瘤中,ALCAM 过表达,并作为疾病进展的有价值的预后标志物。此外,CD166 已被确定为某些癌症中的推定癌症干细胞标志物。在此,我们总结了 ALCAM 的生化方面,包括结构、蛋白水解脱落、选择性剪接和特定配体,并将这些信息与该糖蛋白的生物学功能整合在一起,包括细胞黏附、迁移和侵袭。此外,我们讨论了不同肿瘤类型中 ALCAM 的不同表达模式及其对肿瘤进展的贡献。最后,我们强调了 ALCAM 作为癌症干细胞标志物的作用,并介绍了与该分子相关的当前临床试验。未来的研究需要确定脱落的 ALCAM 在生物流体中的价值,或作为肿瘤进展中预后生物标志物的 ALCAM 同工型表达。

相似文献

1
ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression.ALCAM/CD166:一种多功能细胞黏附、干细胞特性和癌症进展的介导体。
Cytokine Growth Factor Rev. 2021 Oct;61:27-37. doi: 10.1016/j.cytogfr.2021.07.001. Epub 2021 Jul 9.
2
The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker.活化白细胞细胞黏附分子 (ALCAM) 在癌症进展、侵袭、转移和复发中的作用:一种新的癌症干细胞标志物和肿瘤特异性预后标志物。
Exp Mol Pathol. 2020 Aug;115:104443. doi: 10.1016/j.yexmp.2020.104443. Epub 2020 May 5.
3
Modulation of cell adhesion and migration through regulation of the immunoglobulin superfamily member ALCAM/CD166.通过调节免疫球蛋白超家族成员 ALCAM/CD166 来调节细胞黏附和迁移。
Clin Exp Metastasis. 2019 Apr;36(2):87-95. doi: 10.1007/s10585-019-09957-2. Epub 2019 Feb 18.
4
Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse.胰腺癌中活化白细胞黏附分子/CD166表达增加是生存率低和肿瘤早期复发的独立预后标志物。
Br J Cancer. 2009 Aug 4;101(3):457-64. doi: 10.1038/sj.bjc.6605136. Epub 2009 Jul 14.
5
Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer.活化白细胞细胞黏附分子(ALCAM)是复发的标志物,并促进早期子宫内膜样子宫内膜癌中的细胞迁移、侵袭和转移。
J Pathol. 2017 Mar;241(4):475-487. doi: 10.1002/path.4851. Epub 2017 Jan 23.
6
ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone.ALCAM/CD166 是 TGF-β 的反应性标志物,也是前列腺癌骨转移的功能调节剂。
Cancer Res. 2014 Mar 1;74(5):1404-15. doi: 10.1158/0008-5472.CAN-13-1296. Epub 2014 Jan 2.
7
Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth.双重敲低半乳糖凝集素-8及其糖基化配体激活白细胞细胞黏附分子(ALCAM/CD166)可协同延缓体内乳腺癌生长。
Biochim Biophys Acta Mol Cell Res. 2019 Aug;1866(8):1338-1352. doi: 10.1016/j.bbamcr.2019.03.010. Epub 2019 Mar 21.
8
Activated leukocyte cell adhesion molecule expression and shedding in thyroid tumors.甲状腺肿瘤中活化白细胞细胞黏附分子的表达和脱落。
PLoS One. 2011 Feb 22;6(2):e17141. doi: 10.1371/journal.pone.0017141.
9
Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells.半乳糖凝集素-8与活化白细胞细胞黏附分子(ALCAM/CD166)的糖基化依赖性结合促进其在乳腺癌细胞表面的分离。
Biochim Biophys Acta. 2016 Oct;1860(10):2255-68. doi: 10.1016/j.bbagen.2016.04.019. Epub 2016 Apr 26.
10
Prognostic Impact of Activated Leucocyte Cell Adhesion Molecule (ALCAM/CD166) in Infantile Neuroblastoma.活化白细胞细胞黏附分子(ALCAM/CD166)在婴儿神经母细胞瘤中的预后影响
Anticancer Res. 2016 Aug;36(8):3991-5.

引用本文的文献

1
The OT-II model reveals dual and immunomodulatory properties of CD6 in T cell activation.OT-II模型揭示了CD6在T细胞活化中的双重及免疫调节特性。
Front Immunol. 2025 Jun 26;16:1571590. doi: 10.3389/fimmu.2025.1571590. eCollection 2025.
2
CD133 and CD166 Stem Cells Markers Expression, Clinicopathological Parameters, and Fragmentation Response Patterns of ypT3 Rectal Cancer Following Neoadjuvant Chemoradiotherapy.新辅助放化疗后ypT3期直肠癌的CD133和CD166干细胞标志物表达、临床病理参数及分割反应模式
Biomedicines. 2025 May 26;13(6):1300. doi: 10.3390/biomedicines13061300.
3
Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence.
靶向癌症干细胞以克服耐药性和肿瘤复发的纳米材料。
Front Oncol. 2025 Jun 6;15:1499283. doi: 10.3389/fonc.2025.1499283. eCollection 2025.
4
IFITM1 as a modulator of surfaceome dynamics and aggressive phenotype in cervical cancer cells.IFITM1作为子宫颈癌细胞表面组动力学和侵袭性表型的调节因子。
Oncol Rep. 2025 Jun;53(6). doi: 10.3892/or.2025.8904. Epub 2025 May 2.
5
Nanotherapeutic strategies exploiting biological traits of cancer stem cells.利用癌症干细胞生物学特性的纳米治疗策略。
Bioact Mater. 2025 Apr 3;50:61-94. doi: 10.1016/j.bioactmat.2025.03.016. eCollection 2025 Aug.
6
Single-cell profiling reveals the intratumor heterogeneity and immunosuppressive microenvironment in cervical adenocarcinoma.单细胞分析揭示了宫颈腺癌的肿瘤内异质性和免疫抑制微环境。
Elife. 2025 Mar 11;13:RP97335. doi: 10.7554/eLife.97335.
7
Correlation of GD2 Biosynthesis Enzymes With Cancer Stem Cell Markers in Human Breast Cancer.人乳腺癌中GD2生物合成酶与癌症干细胞标志物的相关性
Cancer Genomics Proteomics. 2025 Mar-Apr;22(2):231-246. doi: 10.21873/cgp.20498.
8
ALCAM is an entry factor for severe community acquired Pneumonia-associated Human adenovirus species B.活化白细胞黏附分子是严重社区获得性肺炎相关的B种人类腺病毒的一种进入因子。
Nat Commun. 2024 Dec 30;15(1):10889. doi: 10.1038/s41467-024-55261-3.
9
Rhaponticin suppresses the stemness phenotype of gastric cancer stem-like cells CD133+/CD166 + by inhibiting programmed death-ligand 1.瑞波西汀通过抑制程序性死亡配体 1 抑制胃癌干细胞样细胞 CD133+/CD166+的干性表型。
BMC Gastroenterol. 2024 Nov 21;24(1):423. doi: 10.1186/s12876-024-03512-4.
10
Comparison of functional characterization of cancer stem cells in different tumor tissues of pseudomyxoma peritonei.比较腹膜假黏液瘤不同肿瘤组织中癌症干细胞的功能特征。
J Transl Med. 2024 Nov 14;22(1):1022. doi: 10.1186/s12967-024-05730-6.